[PDF][PDF] Perbandingan Skor Sokal dan Skor Hasford terhadap Respons Terapi Imatinib Mesylate pada Pasien Leukemia Granulositik Kronis di Rumah Sakit dr
S Somarnam, BD Machsoos… - Saiful Anwar Malang …, 2019 - scholarhub.ui.ac.id
ABSTRAK Pendahuluan. Skor Sokal dan Hasford berkembang sebelum era terapi tirosine
kinase inhibitor (TKI) untuk memberikan prediksi dan prognosis hasil terapi pasien leukemia …
kinase inhibitor (TKI) untuk memberikan prediksi dan prognosis hasil terapi pasien leukemia …
Association between Hasford scoring system and hematologic response in chronic and accelerated phase of chronic myelocytic leukemia patient with imatinib for …
A Purnomo, SUY Bintoro, MP Sedana… - Molecular and …, 2019 - repository.unair.ac.id
Background: Hasford score is a scoring system which was made in interferon treatment era
to assess chronic myelocytic leukemia (CML) prognosis. Complete hematologic response …
to assess chronic myelocytic leukemia (CML) prognosis. Complete hematologic response …
Therapeutic responses of imatinib and nilotinib among CML patients in Hasan Sadikin Hospital Bandung
AF Sumantri, A Oehadian… - Indonesian …, 2019 - mail.indonesianjournalofcancer.or.id
Abstract Introduction: Chronic Myeloid Leukemia (CML) is a myeloproliferative malignancy
with an estimated incidence in the world of 1-2 cases per 100,000 adults. The use of …
with an estimated incidence in the world of 1-2 cases per 100,000 adults. The use of …
Correlation between hasford score with early molecular response in patients with chronic myeloid leukemia in chronic phase treated with imatinib
IDMW Hersana, SUY Bintoro… - Biomedical & …, 2019 - repository.unair.ac.id
Telah diperiksa dan divalidasi dengan baik, dan sampai pemyataan ini dibuat sebagai
karya ilmiah original, fhgne $ r sehingga kami turut bertanggung jawab bahwa karya ilmiah …
karya ilmiah original, fhgne $ r sehingga kami turut bertanggung jawab bahwa karya ilmiah …
Comparative study of clinico-hematological features, molecular spectrum and response to imatinib in chronic myelogenous leukemia patients: pediatric and …
A Tahlan, N Varma, S Naseem, D Bansal… - Indian Journal of …, 2018 - Springer
Chronic myelogenous leukemia (CML) is a rare disease in children, accounting for
approximately 3% of leukemias in children and adolescents, with an annual incidence of 1 …
approximately 3% of leukemias in children and adolescents, with an annual incidence of 1 …
Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib
AA Prayoga, SUY Bintoro - Acta Medica Indonesiana, 2014 - repository.unair.ac.id
Tujuan: mengevaluasi pola dari respons molekular yang dinilai dengan reduksi kadar
transkrip BCR-ABL berdasarkan skor prognosis sokal pada pasien leukemia mieloid kronis …
transkrip BCR-ABL berdasarkan skor prognosis sokal pada pasien leukemia mieloid kronis …
Prognostic Implications of Sokal, Hasford, and EUTOS scores on Complete Hematologic and Early Molecular Responses in Newly Diagnosed Chronic Myeloid …
Sokal, Hasford, and EUTOS prognostic scoring systems are widely used for chronic myeloid
leukemia (CML) patients. However, whether one of these scoring systems was better …
leukemia (CML) patients. However, whether one of these scoring systems was better …
Preliminary report: clinical characteristic, hematologic response and gene mutation of patients with chronic phase chronic myeloid leukemia (CML) to imatinib at Cipto …
AH Reksodiputro, H Tadjoedin… - Indonesian …, 2011 - indonesianjournalofcancer.or.id
Abstract Leukemia Granulositik Kronik (LGK) disebabkan oleh gen BCR-Abl domaintyrosin
kinase, produk dari kromosom Philadelphia. Imatinib mesylate merupakan inhibitor selektif …
kinase, produk dari kromosom Philadelphia. Imatinib mesylate merupakan inhibitor selektif …
[PDF][PDF] Clinical characteristics and hematologic responses to Imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital
AH Reksodiputro, S Syafei, N Prayogo, B Karsono… - Acta Med …, 2010 - academia.edu
Aim: to analyze the clinical characteristics of patients with chronic phase CML and evaluate
complete hematologic responses (CHR) and overall survival (OS) after treatment with …
complete hematologic responses (CHR) and overall survival (OS) after treatment with …
[PDF][PDF] The utility and applicability of chronic myeloid leukemia scoring systems for predicting the prognosis of Egyptian patients on Imatinib: retrospective study
TA Elbedewy, HE Elashtokhy - J Leuk, 2016 - researchgate.net
Background: Chronic myeloid leukemia (CML) is myeloproliferative clonal neoplasm.
Imatinib has greatly improved CML prognosis. Many prognostic scoring systems have been …
Imatinib has greatly improved CML prognosis. Many prognostic scoring systems have been …